Top of this page
Skip navigation, go straight to the content
Scroll down to discover UCB
UCB0599
| Disease area studied |
Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
Parkinson's Disease (PD) |
A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease |
PD0053 Ongoing |
NCT04658186 |